FTLP6

Across TCGA pan-cancer cohorts, FTLP6 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated FTLP6 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher FTLP6 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FTLP6 expression acts as an unfavorable survival marker, although some lineages such as HNSC and OV show a favorable association.

DLBC, KIRC, and UVM are the cancer types where FTLP6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Tertile	IV	0.151	0.812	<.001	77	view →
KIRC	DFS	Median	III,IV	0.555	0.683	.002	73	view →
UVM	DFS	Tertile	III,IV	0.032	0.727	<.001	72	view →
HNSC	OS	Quartile	II,III,IV	0.833	0.705	.009	53	view →
BRCA	DFS	Quartile	II,III,IV	0.457	0.523	.001	35	view →
UCEC	OS	Tertile	All	0.903	0.934	.034	24	view →
ACC	DFS	Tertile	III,IV	0.046	0.670	.001	24	view →
OV	OS	Tertile	All	0.388	0.282	.015	16	view →
READ	OS	Tertile	All	0.887	0.572	.037	12	view →
KIRP	DFS	Median	IV	0.621	0.041	.012	12	view →
ESCA	OS	Quartile	III,IV	0.610	0.251	.016	6	view →
COAD	DFS	Tertile	III,IV	0.516	0.727	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

FTLP6–DLBC (DFS)

Open the DLBC breakdown →